Is BBOT diluting shareholders?

Read three numbers together: shares outstanding over time (80.1M as of 2026-05-07), warrants that can convert into new shares, and how much cash runway remains (~26.5799778741637 months). A company short on cash with live registrations is structurally likely to issue shares.

Where do these numbers come from?

SEC EDGAR only: the XBRL company-facts API for shares, warrants and cash, and filing metadata for registrations and pricings. Every figure shows its source form, and nothing here is estimated by us beyond the arithmetic stated next to it.

Why might a warrant tranche be missing from the table?

The tranche table is built from the dimensions the company tagged in its own 10-Q or 10-K XBRL. A tranche the filer chose not to dimension does not appear, and its absence proves nothing: the exhibits remain the ground truth. Everything shown carries the filing it came from.

Dilution profile // every instrument, one screen, from SEC filings

BridgeBio Oncology Therapeutics, Inc. (BBOT)

CIK 1869105 · all EDGAR filings →

Overall dilution risk

HIGHworst of 3 computed signals (offering ability)

= the worst band among the computed sub-ratings, no hidden weighting

not every sub-rating was computable; treat as a floor

Offering ability

HIGH$586M registered

= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)

one or more live registrations had no structured fee data, so the true total is AT LEAST this

Overhead supply

NOT COMPUTEDno warrant count tagged in XBRL

= warrant shares outstanding divided by current shares outstanding

absence of a tag is not proof of absence of warrants

Historical dilution

LOW0% O/S in 3y

= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative

Cash need

LOW~26.6 months of runway

= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Latest: 80.1M shares as of May 7, 2026 (10-Q).

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed May 12, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $586.4Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-1Aug 29, 2025$586.4M registeredfiling →

S-1Jan 18, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 1 executed · 1 registered.

UPDATEJun 22, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATEMay 13, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATEMay 6, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVEMay 4, 2026SEC declared a registration effective — selling can beginEFFECT →

UPDATEApr 29, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATEApr 23, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATEMar 26, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATEMar 6, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATEJan 7, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATESep 10, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVESep 10, 2025SEC declared a registration effective — selling can beginEFFECT →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full BBOT workspace